An Innovative Conversational Agent (Quitbot) for Smoking Cessation

Complete Title: Full Scale Randomized Trial of an Innovative Conversational Agent for Smoking Cessation (QuitBot)
Trial Phase: III
Investigator: Jonathan Bricker

This phase III trial compares two remote digital smoking cessation programs to see how well they work for quitting smoking.

Keywords:
  • Carcinoma
Disclaimer: We update this information regularly. However, what you read today may not be completely up to date.
Checklist icon

Join a Clinical Trial

Whether you are eligible for a research study depends on many things. There are specific requirements to be in research studies. These requirements are different for each clinical trial.

Contact Us

If you are seeking to schedule an appointment, we are here to help. You can either call us or fill out our online appointment request form.

Adult
III
Jonathan Bricker
RG1006844
NCT04308759
Full Scale Randomized Trial of an Innovative Conversational Agent for Smoking Cessation (QuitBot)
Carcinoma